PDS Biotechnology | 10-Q: Q3 2024 Earnings Report
PDS Biotechnology | 8-K: PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results
PDS Biotechnology | 8-K: Current report
PDS Biotechnology | 8-K: Current report
PDS Biotechnology | 8-K: Current report
PDS Biotechnology | 424B5: Prospectus
PDS Biotechnology | 8-K: Current report
PDS Biotechnology | 10-Q: Q2 2024 Earnings Report
PDS Biotechnology | 8-K: PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
PDS Biotechnology | 8-K: Current report
PDS Biotechnology | 8-K: Current report
PDS Biotechnology | 8-K: Current report
PDS Biotechnology | 8-K: Current report
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Freitag Gregory Gene
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Glover Stephen C.
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Ali-Jackson Kamil
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director BRAWLEY OTIS W
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director Iliev Ilian
PDS Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SYKES RICHARD
PDS Biotechnology | 8-K: Current report
No Data
No Data